News

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 ...
Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...
A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and help overcome both diabetes and obesity, a new clinical trial suggests.